Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid
Back to article page
|Updated:2021-08-27
|
Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid
Chinese Journal of Integrative MedicineVol. 10, Issue 3, Pages: 203-207(2004)
Affiliations:
Nephropathy Department, The First Affiliated Hospital to Anhui College of TCM,Hefei,China
Yong, L., Yi-ping, W. & Li, Z. Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid., Chin. J. Integr. Med. 10, 203–207 (2004). https://doi.org/10.1007/BF02836408
Lu Yong, Wang Yi-ping, Zhang Li. Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid. [J]. Chinese Journal of Integrative Medicine 10(3):203-207(2004)
Yong, L., Yi-ping, W. & Li, Z. Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid., Chin. J. Integr. Med. 10, 203–207 (2004). https://doi.org/10.1007/BF02836408DOI:
Lu Yong, Wang Yi-ping, Zhang Li. Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid. [J]. Chinese Journal of Integrative Medicine 10(3):203-207(2004) DOI: 10.1007/BF02836408.
Study of interference treatment by Xuesaitong soft capsule on patients of nephrosis syndrome with Qi deficiency and blood stasis during dose reducing stage of corticosteroid
摘要
Objective: To observe the effect of Xuesaitong (XST) soft capsule in interference treatment on patients of nephrosis syndrome (NS) during corticosteroid (CS) dose reducing stage.Methods: Seventy-one NS patients applying prednisone and initiating dose reducing stage were randomized into trial group and control group. On the basis of conventional prednisone dose reduction of both groups
the trial group was given additionally XST
and the treatment course ended with the reduction to maintenance dose. In the course of observation
those who did not comply with the criteria of observation were excluded. Before and after the dose reduction
TCM syndrome scoring
24 hrs urinary protein amount
blood β2-microglobulin (β2-MG)
urinary β2-MG
blood fibrinogen (Fbg)
plasma prothrombin time (PT)
blood lipid
etc. were observed.Results: The trial group of XST could obviously lower their urinary protein amount and blood lipid level (P<0.05 orP<0.01)
markedly improve the blood coagulation parameters (P<0.01)
improve the TCM syndrome and CS induced adverse reaction (P<0.05 orP<0.01)
also obviously reduced the recurrence rate of NS (P<0.05).Conclusion: XST could obviously improve the clinical symptoms and renal impairment parameters in NS patients during CS dose reduction stage
improve the CS induced adverse reaction and prevent the recurrence of NS.
Abstract
Objective: To observe the effect of Xuesaitong (XST) soft capsule in interference treatment on patients of nephrosis syndrome (NS) during corticosteroid (CS) dose reducing stage.Methods: Seventy-one NS patients applying prednisone and initiating dose reducing stage were randomized into trial group and control group. On the basis of conventional prednisone dose reduction of both groups
the trial group was given additionally XST
and the treatment course ended with the reduction to maintenance dose. In the course of observation
those who did not comply with the criteria of observation were excluded. Before and after the dose reduction
TCM syndrome scoring
24 hrs urinary protein amount
blood β2-microglobulin (β2-MG)
urinary β2-MG
blood fibrinogen (Fbg)
plasma prothrombin time (PT)
blood lipid
etc. were observed.Results: The trial group of XST could obviously lower their urinary protein amount and blood lipid level (P<0.05 orP<0.01)
markedly improve the blood coagulation parameters (P<0.01)
improve the TCM syndrome and CS induced adverse reaction (P<0.05 orP<0.01)
also obviously reduced the recurrence rate of NS (P<0.05).Conclusion: XST could obviously improve the clinical symptoms and renal impairment parameters in NS patients during CS dose reduction stage
improve the CS induced adverse reaction and prevent the recurrence of NS.
关键词
nephrosis syndromecorticosteroidQi deficiency and blood stasisXuesaitong soft capsule
Keywords
nephrosis syndromecorticosteroidQi deficiency and blood stasisXuesaitong soft capsule
references
Wang HY, Zheng FL, Liu YC. Minutes of Primary gb merulopathy typing and treatment and diagnosis standard special topic symposium. Chin J Intern Med 1993; 32 (2): 131–134.
Ye RG chief editor. Internal Medicine. 5th edition. Beijing; People’s Medical Publishing House, 2001: 539.
Ministry of Health,P. R. China. Guiding principle of TCM new drugs for clinical study. 1995; Vol2:1,9.
Sun XM, Yao Y, Ji SJ, et al. The effect of Notoginseng saponin on plasma granulomembrane protein and platelet aggregation of coronary heart disease patients. Mathematic Physiol J Med 201; 14(1): 26–27.
Xu HL, Liu WB, Rao MR. Effect of Panax Notoginseng saponin Rg1 on experimental thrombosis and exploration of its mechanism. Acad J Pharmacy 1997;32(7): 502.
Wei Y, Fan JM, Pan LP. Effect of PNS on human renal fibroblast. Chin J Integr Tradit West Med 2002; 22 (1): 47–49.
Zheng HX, Chen SR, Sheng CH, et al. Experimental study of protective effect of PNS on initial stage acute tubular necrosis in rabbits. Nephropath J Dialy Transplant 1996;5(4): 15–20.
Zhou XL, Li YW, Li FC. Experimental study of PNS on immune function in rats. Guangxi Med Univ Acad J 2001;18(3): 360–361.
Shen Y, Liu H, Zhang JL. Effect of crude notoginseng on RBC immune adhesive function of mesangial proliferative glomerulonephritis. Chin J Integr Tradit West Med Nephropathy 2002;3(8): 491.
Zheng GZ. The biology and application of notoginseng. Beijing: Science Press, 1994: 68.
Yan XW. Efficacy observation of PNS tablet on hyperviscosity and hyperlipidemia. Shanghai J TCM 1999; 5: 19.
Cai GY, Xu XM. Effect of PNS on free radical and RBC membrane fluidity of chronic renal failure patients. Chin J Nephrol 1997;13(4): 240–241.
Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction
Clinical observation of the effect of Xuesaitong soft capsule on post-hepatitis fibrosis
Clinical controlled study of integrative Chinese and western medicine in treating 49 cases of SARS
Clinical Study of Weishu capsule ( ) in treating precancerous lesions of chronic atrophic gastritis) in treating precancerous lesions of chronic atrophic gastritis
Related Author
No data
Related Institution
The Second People’s Hospital of Liaocheng
The First Hospital Affiliated to Medical College of Zhejiang University
Wangjing Hospital, China Academy of Traditional Chinese Medicine
Beijing Tiantan Hospital
Institute of Digestive Diseases, Jiangsu Provincial Hospital of Traditional Chinese Medicine